| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.5 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |